Biofidelity and CellCarta partner to deploy Aspyre Lung in global clinical trials
New partnership to advance precision medicine in lung cancer diagnosis Biofidelity and CellCarta have announced a strategic partnership to utilise...
Selected News
Actinogen boosts trial with Cambridge Cognition’s digital suite
Partnership aims to advance Alzheimer's research with innovative tools Cambridge Cognition Holdings plc has expanded its partnership with Actinogen Medical...
Owlstone Medical announces $27 million USD first close in Series E financing round
Funds to accelerate commercialisation and clinical trials of diagnostic tests Owlstone Medical has announced a first close of $27 million...
Oxford Drug Design achieves in vivo validation for novel cancer treatment
Promising results from mouse study lead to expanded trials Oxford Drug Design, the Oxford-based AI drug discovery company, has announced...
Pheno Therapeutics granted trial authorisation for MS candidate
First-in-human trial of PTD802 to commence following UK MHRA approval Pheno Therapeutics Limited has received clinical trial authorisation (CTA) from...
Grifols pioneers high-tech analysis of plasma bank to detect Parkinson’s disease
Initiative aims to identify plasma-based biomarkers for early detection Grifols has received a grant from The Michael J. Fox Foundation...
AI set to revolutionise pharmaceutical R&D says GlobalData
Survey finds AI to enhance productivity and cut costs in the next 12 months AI is poised to significantly lower...
Gilead and LEO Pharma partner to develop oral STAT6 program
Companies aim to provide new treatments for inflammatory conditions Gilead Sciences and LEO Pharma have announced a strategic partnership to...
New therapy hope for prostate cancer patients
CR-discovered NXP800 shows promise in clinical trials Prostate cancer resistant to hormone therapy could soon have a new treatment option....
NICE recommends olaparib for BRCA-mutated breast cancer treatment
Groundbreaking approval provides new hope for patients in England and Wales The National Institute for Health and Care Excellence (NICE)...
Cambridge Cognition highlights positive Cantab results
New FDA-approved schizophrenia treatment shows promise in clinical trials Cambridge Cognition has praised Bristol Myers Squibb for the FDA approval...
Angelini Ventures co-leads Series A financing in Neumirna Therapeutics
Investment to support RNA therapeutics for epilepsy and neurological disorders Angelini Ventures has co-led a €20 million Series A financing...
Novartis gene therapy set to enhance SMA treatment
OAV101 IT expands potential for type II SMA patients Novartis has announced that its intrathecal (IT) formulation of onasemnogene abeparvovec...
Merck unveils new cyber-physical trust platform at CES 2025
M-Trust set to improve product safety and counterfeiting solutions Merck has launched the beta version of M-Trust, a pioneering cyber-physical...
New prostate cancer test cuts biopsies by 50% in US
EpiSwitch PSE shows promise in reducing unnecessary procedures Kearney Urology Center has reported a 50% reduction in biopsies since adopting...
Amgen’s lung cancer treatment gets conditional approval
IMDYLLTRA offers new hope for patients with extensive-stage small cell lung cancer The UK’s Medicines and Healthcare products Regulatory Agency...
NHS Confederation welcomes social care commission announcement
Government announces independent commission on social care The government has announced the creation of an independent commission on social care....
FDA approves Sequana Medical’s Alfapump for ascites treatment
FDA gives green light to innovative device for liver conditions Sequana Medical NV has announced the US FDA approval of...
EC approves Rybrevant with Lazcluze for advanced lung cancer
New chemotherapy-free treatment shows promise for EGFR-mutated NSCLC Janssen-Cilag International NV, a Johnson & Johnson company, announced that the European...
UK regulator warns against buying weight-loss medicines without prescription
MHRA urges caution over illegal medicines from beauty salons and social media The Medicines and Healthcare products Regulatory Agency (MHRA)...
